RE:As predicted. shorting awayAlso, people need to realize, everything has steps of progress.
The endorcement of GCAR, & in plain English says
" registration-enabling pathway"
Now? what about a partner to help pay for all this , or a buyout?
Stay tuned grasshopper.....
One step at a time.
Oncolytics has just announced ...up-coming trial ascoicated with a world repected Pancreatic cancer organization.
Certianly not a fraud as some meatheads have proclaimed.
No, they have additional fodder for negotiations with existing or new potential partners.
Great opportunities at that. Regrettably a few want answers last week. Want a partnership, buyout NOW....
Pointiing to lack of that , only indicates now.
last week for example, the same FUDSTERS were saying " what happned to the phase 3 panc trial..it disapeared" .
Well not gone, just imporved.
The CGAR trial by the announcment will be less costly, quicker and expected to lead directly to licensing.
Just read the N.R.